Investor Relations
Investor Presentation
View our Investor Presentation for a quick synopsis of why we believe NEOGEN remains a solid choice for investors — including the innovative food and animal safety solutions that we offer to our expanding markets.
NEOGEN’s new AccuPoint Advanced Next Generation (NG) system features a more modernized and user-friendly handheld device, with an easy-to-use ergonomic design.
Third quarter net income was $13,377,000, up 10% compared to the prior year’s $12,200,000.
Papesh joined NEOGEN’s Board in October 1993, and has helped guide the company from approximately $8 million in annual revenues to approximately $418 million in revenues in its most recently completed fiscal year (May 31).
NEOGEN’s Early Warning solution is a piloted, accurate, and reliable test to monitor for the presence of SARS-CoV-2, the virus known to cause COVID-19, in sludge from wastewater facilities.
While hypothyroidism can’t be cured, daily replacement therapy with products such as ThyroKare allows for dogs to live full, normal lives following diagnosis.
The new test is designed for use with NEOGEN’s Raptor® Integrated Analysis Platform, which controls the timing, temperature and reading of the test strips — allowing testers to simply add sample and walk away.
Quarterly Reports
Fiscal year is June 1 - May 31
Fiscal Year 2021
- 1st Quarter, Conference Call, 10Q
- 2nd Quarter, Conference Call, 10Q
- 3rd Quarter, Conference Call, 10Q
- 4th Quarter, Conference Call, 10K
Fiscal Year 2020
- 1st Quarter, Conference Call, 10Q
- 2nd Quarter, Conference Call, 10Q
- 3rd Quarter, Conference Call, 10Q
- 4th Quarter, Conference Call, 10K
Virtual Annual Shareholders’ Meeting: October 8 at 10:00 am ET
Play Back
Annual Reports
To learn more about what NEOGEN does, check out our Annual Report. NEOGEN’s Annual Report includes audited financial statements with additional perspective from our management team. The Form 10-K contains the audited financial statements, and also offers a comprehensive look at the overall business.
Previous Reports
Form 10-K
Additional Information
Contact Information
NEOGEN's Investor Relations
620 Lesher Place, Lansing, MI 48912
ir@NEOGEN.com
Shareholder Inquiries
Transfer Agent and Registrar
American Stock Transfer & Trust
59 Maiden Lane
New York, NY 10038
Get a stock quote on NEOGEN Corporation from NASDAQ.